Gentamicin blood levels: a guide to nephrotoxicity

Area of Science:

• Pharmacology
• Nephrology
• Clinical Chemistry

Background:

• Gentamicin is an antibiotic requiring therapeutic drug monitoring.
• Nephrotoxicity is a significant adverse effect of gentamicin therapy.
• Predicting and preventing gentamicin-induced kidney damage is crucial.

Purpose of the Study:

• To investigate the correlation between gentamicin blood levels and nephrotoxicity.
• To determine the predictive value of trough (valley) gentamicin levels for renal impairment.
• To assess the relationship between gentamicin dosing, peak/trough levels, and renal function.

Main Methods:

• Prospective monitoring of gentamicin blood levels (peak and trough) in 86 patients.
• Measurement of serum creatinine to assess renal function.
• Validation of gentamicin assay methods using radioenzymatic and agar diffusion techniques.
• Correlation analysis between gentamicin levels, dosage, and development of nephrotoxicity.

Main Results:

• Twenty-one patients with trough gentamicin levels > 2 mug/ml showed a 36% incidence of abnormal serum creatinine.
• No patient developed renal impairment without trough levels exceeding 2 mug/ml.
• Peak gentamicin levels > 10 mug/ml were not consistently associated with nephrotoxicity.
• Higher daily gentamicin doses (4.5 mpk) correlated with increased peak and trough levels and nephrotoxicity compared to lower doses (3.0 mpk).
• Assay methods were statistically identical.

Conclusions:

• Gentamicin trough levels > 2 mug/ml may serve as an early indicator of potential renal impairment.
• Monitoring trough levels is valuable for predicting gentamicin accumulation and associated nephrotoxicity.
• Therapeutic drug monitoring, particularly of trough levels, can guide gentamicin dosing to minimize kidney damage.